Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081061 | SCV000112968 | benign | not specified | 2014-04-28 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000145767 | SCV000192895 | uncertain significance | Rubinstein-Taybi syndrome due to CREBBP mutations | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000081061 | SCV000257959 | benign | not specified | 2015-06-05 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000224624 | SCV000281584 | benign | not provided | 2015-12-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001085724 | SCV000754213 | benign | Rubinstein-Taybi syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311611 | SCV000846039 | likely benign | Inborn genetic diseases | 2018-01-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000224624 | SCV000892451 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | CREBBP: PP2, BP4, BS1 |
Gene |
RCV000224624 | SCV001888925 | benign | not provided | 2019-10-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23891399, 27884173, 22591219) |
Al Jalila Children's Genomics Center, |
RCV000081061 | SCV001984302 | benign | not specified | 2020-03-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003982877 | SCV004796146 | benign | CREBBP-related disorder | 2019-05-04 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV000224624 | SCV002034967 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000224624 | SCV002036852 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000224624 | SCV002038171 | likely benign | not provided | no assertion criteria provided | clinical testing |